Evidence-Based Medicine Guidelines
Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease
Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Topical Cystic Fibrosis Transmembrane Conductance Regulator Gene Replacement for Cystic Fibrosis-related Lung Disease." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452414/all/Topical_cystic_fibrosis_transmembrane_conductance_regulator_gene_replacement_for_cystic_fibrosis_related_lung_disease.
Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/452414/all/Topical_cystic_fibrosis_transmembrane_conductance_regulator_gene_replacement_for_cystic_fibrosis_related_lung_disease. Accessed March 30, 2023.
Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/452414/all/Topical_cystic_fibrosis_transmembrane_conductance_regulator_gene_replacement_for_cystic_fibrosis_related_lung_disease
Topical Cystic Fibrosis Transmembrane Conductance Regulator Gene Replacement for Cystic Fibrosis-related Lung Disease [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452414/all/Topical_cystic_fibrosis_transmembrane_conductance_regulator_gene_replacement_for_cystic_fibrosis_related_lung_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease
ID - 452414
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452414/all/Topical_cystic_fibrosis_transmembrane_conductance_regulator_gene_replacement_for_cystic_fibrosis_related_lung_disease
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
